Literature DB >> 22227591

In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation.

Antonia Moretta1, Gabriella Andriolo, Daniela Lisini, Miryam Martinetti, Annamaria Pasi, Paolo Rebulla, Davide Soligo, Rosaria Giordano, Lorenza Lazzari, Rita Maccario.   

Abstract

The transplantation of two cord blood (CB) units obtained from unrelated donors (double CBT) is an effective strategy for adult patients with hematologic malignancies. Sustained hematopoiesis after double CBT is usually derived from a single donor, and only a few transplantation recipients displaying a stable mixed donor-donor chimerism have been reported. We investigated the mechanisms underlying single-donor predominance in double CBT by studying in vitro the role of the graft-versus-graft cell-mediated immune effect in two-way mixed-lymphocyte culture, along with the contribution of differential hematopoietic progenitor (HP) potency in HP mixed cultures. Results for the two-way mixed-lymphocyte culture showed that despite the weak and variable alloantigen-specific cytotoxic potential displayed by CB mononuclear cells, an immune-mediated dominance for one of the two CB units was detected in the majority of experiments. Alloantigen-induced cytotoxic activity was directed toward both CB-HP and phytohemagglutinin (PHA)-activated T lymphoblastoid cells. The CB unit with the higher fold expansion of CD34(+) cells in single-expansion culture was prevalent in the HP mixed-expansion culture, as shown by DNA chimerism evaluation. Based on these data, we hypothesize that the dominant CB unit is able to develop prevalent cytotoxic activity toward activated lymphocytes of the other CB unit, thereby preventing them from exerting alloantigen-specific cytotoxic potential against both activated lymphocytes and HPs of the dominant unit. In accordance with this hypothesis, we propose the evaluation of alloantigen-induced cytotoxic activity generated in two-way mixed-lymphocyte culture and directed toward PHA-activated T lymphoblastoid cells as a tool to identify the potentially predominant CB unit before double CBT.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227591     DOI: 10.1016/j.bbmt.2011.12.586

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

Review 1.  Graft predominance after double umbilical cord blood transplantation: a review.

Authors:  Jan J Cornelissen; Burak Kalin; Cor H J Lamers
Journal:  Stem Cell Investig       Date:  2017-05-26

2.  Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment.

Authors:  Mitchell E Horwitz; Nelson J Chao; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Carolyn McDonald; Barbara Waters-Pick; Patrick Stiff; Steven Wease; Amnon Peled; David Snyder; Einat Galamidi Cohen; Hadas Shoham; Efrat Landau; Etty Friend; Iddo Peleg; Dorit Aschengrau; Dima Yackoubov; Joanne Kurtzberg; Tony Peled
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

3.  Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation.

Authors:  Mitchell E Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

4.  Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood.

Authors:  E V Sotnezova; E R Andreeva; A I Grigoriev; L B Buravkova
Journal:  Acta Naturae       Date:  2016 Jul-Sep       Impact factor: 1.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.